First Time Loading...
C

Cibus Inc
NASDAQ:CBUS

Watchlist Manager
Cibus Inc
NASDAQ:CBUS
Watchlist
Price: 16.94 USD 6.94% Market Closed
Updated: Apr 30, 2024

Wall Street
Price Targets

CBUS Price Targets Summary
Cibus Inc

Wall Street analysts forecast CBUS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CBUS is 23.46 USD with a low forecast of 19.19 USD and a high forecast of 26.25 USD.

Lowest
Price Target
19.19 USD
13% Upside
Average
Price Target
23.46 USD
38% Upside
Highest
Price Target
26.25 USD
55% Upside
Cibus Inc Competitors:
Price Targets
086900
Medy Tox Inc
78% Upside
SPRO
Spero Therapeutics Inc
428% Upside
MYGN
Myriad Genetics Inc
26% Upside
048530
iNtRON Biotechnology Inc
135% Upside
TWST
Twist Bioscience Corp
29% Upside
AVCT
Avacta Group PLC
95% Upside
086890
Isu Abxis Co Ltd
119% Upside
300142
Walvax Biotechnology Co Ltd
53% Upside

Revenue
Forecast

Revenue Estimate
Cibus Inc

For the last 7 years the compound annual growth rate for Cibus Inc's revenue is 24%. The projected CAGR for the next 3 years is 180%.

24%
Past Growth
180%
Estimated Growth
Estimates Accuracy
13%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Cibus Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Cibus Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-97%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CBUS's stock price target?
Price Target
23.46 USD

According to Wall Street analysts, the average 1-year price target for CBUS is 23.46 USD with a low forecast of 19.19 USD and a high forecast of 26.25 USD.

What is Cibus Inc's Revenue forecast?
Projected CAGR
180%

For the last 7 years the compound annual growth rate for Cibus Inc's revenue is 24%. The projected CAGR for the next 3 years is 180%.